Jeffrey S. Conrad
No más puestos en curso
Perfil
Mr. Jeffrey S.
Conrad is Secretary & Director at Abviva, Inc. and Partner at eFund Capital Management LLC.
He is on the Board of Directors at Abviva, Inc.
Mr. Conrad also served on the board at Probe Manufacturing, Inc.
He received his undergraduate degree from the University of California, Berkeley and a graduate degree from Loyola Law School.
Antiguos cargos conocidos de Jeffrey S. Conrad.
| Empresas | Cargo | Fin |
|---|---|---|
| CLEAN ENERGY TECHNOLOGIES, INC. | Director/Miembro de la Junta | 27/07/2009 |
eFund Capital Management LLC
 eFund Capital Management LLC Investment ManagersFinance eFund Capital Management LLC operated as a private equity fund. The company was headquartered in Long Beach, CA. | Corporate Officer/Principal | - |
Abviva, Inc.
 Abviva, Inc. Medical SpecialtiesHealth Technology Abviva, Inc. develops and commercializes diagnostic and therapeutic products from Mammastatin, a growth-regulatory protein that inhibits breast cancer cell growth. The Mammastatin is normally present in the blood serum of healthy women and absent in women with breast cancer. The company develops breast cancer therapies through internal and external collaborative research with pharmaceutical, biotechnology and leading research institution world wide to commercialize the Mammastatin serum. It was founded on September 19, 1994 and is headquartered in Santa Barbara, CA. | Director/Miembro de la Junta | - |
Formación de Jeffrey S. Conrad.
| University of California, Berkeley | Undergraduate Degree |
| Loyola Law School | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CLEAN ENERGY TECHNOLOGIES, INC. | Producer Manufacturing |
| Empresas privadas | 2 |
|---|---|
Abviva, Inc.
Abviva, Inc. Medical SpecialtiesHealth Technology Abviva, Inc. develops and commercializes diagnostic and therapeutic products from Mammastatin, a growth-regulatory protein that inhibits breast cancer cell growth. The Mammastatin is normally present in the blood serum of healthy women and absent in women with breast cancer. The company develops breast cancer therapies through internal and external collaborative research with pharmaceutical, biotechnology and leading research institution world wide to commercialize the Mammastatin serum. It was founded on September 19, 1994 and is headquartered in Santa Barbara, CA. | Health Technology |
eFund Capital Management LLC
eFund Capital Management LLC Investment ManagersFinance eFund Capital Management LLC operated as a private equity fund. The company was headquartered in Long Beach, CA. | Finance |
- Bolsa de valores
- Insiders
- Jeffrey S. Conrad
